Hospice 2007 regulatory issues.

Caring

Published: February 2008

Download full-text PDF

Source

Publication Analysis

Top Keywords

hospice 2007
4
2007 regulatory
4
regulatory issues
4
hospice
1
regulatory
1
issues
1

Similar Publications

The accessibility of CAR-T cells in centralized production models faces significant challenges, primarily stemming from logistical complexities and prohibitive costs. However, European Regulation EC No. 1394/2007 introduced a pivotal provision known as the hospital exemption.

View Article and Find Full Text PDF

Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 Patients.

J Clin Med

January 2025

Department of Respiratory Medicine, National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, European Reference Network (ERN)-LUNG, 28 Avenue Doyen Lepine, 69677 Lyon, France.

Antibodies against Ku have been described in patients with various connective tissue diseases. The objective of this study was to describe the clinical, functional, and imaging characteristics of interstitial lung disease in patients with anti-Ku antibodies. : This single-center, retrospective observational study was conducted at a tertiary referral institution.

View Article and Find Full Text PDF

Background: Engaging people in advance care planning is a challenging systemic problem that requires a social innovation approach and a conceptual framework to guide behavioural and social change efforts.

Aim: To identify stakeholders' perspectives on barriers to advance care planning engagement, options for overcoming these barriers, and user needs. The findings will inform the design of a health behaviour change intervention for engaging older adults (50+) in advance care planning.

View Article and Find Full Text PDF

The genome of Hepatitis B virus (HBV) persists in infected hepatocytes as a nuclear episome (cccDNA) that is responsible for the transcription of viral genes and viral rebound, following antiviral treatment arrest in chronically infected patients. There is currently no clinically approved therapeutic strategy able to efficiently target cccDNA (Lucifora J 2016). The development of alternative strategies aiming at permanently abrogating HBV RNA production requires a thorough understanding of cccDNA transcriptional and post-transcriptional regulation.

View Article and Find Full Text PDF

Functional outcomes after supra-pubic phalloplasty.

J Plast Reconstr Aesthet Surg

December 2024

Urology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France; Université Claude Bernard Lyon 1, Lyon, France. Electronic address:

Article Synopsis
  • - The study evaluates the outcomes of supra-pubic phalloplasty (SPP) in terms of sexuality, urinary function, and overall patient satisfaction, focusing on data collected from patients treated between 2007 and 2018.
  • - A total of 77 patients participated, with 33 responding to questionnaires; results indicated high satisfaction levels, a mean neophallus length of 15.3 cm, and favorable sexual and urinary function outcomes.
  • - The findings suggest that pre-expanded SPP is an effective technique, providing significant improvements in appearance and function, along with a high rate of satisfaction regarding the phalloplasty experience.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!